Neu3 neuraminidase induction triggers intestinal inflammation and colitis in a model of recurrent human food-poisoning.
Won Ho YangJulia S WestmanDouglas M HeithoffMarkus SperandioJin Won ChoMichael J MahanJamey D MarthPublished in: Proceedings of the National Academy of Sciences of the United States of America (2021)
Intestinal inflammation is the underlying basis of colitis and the inflammatory bowel diseases. These syndromes originate from genetic and environmental factors that remain to be fully identified. Infections are possible disease triggers, including recurrent human food-poisoning by the common foodborne pathogen Salmonella enterica Typhimurium (ST), which in laboratory mice causes progressive intestinal inflammation leading to an enduring colitis. In this colitis model, disease onset has been linked to Toll-like receptor-4-dependent induction of intestinal neuraminidase activity, leading to the desialylation, reduced half-life, and acquired deficiency of anti-inflammatory intestinal alkaline phosphatase (IAP). Neuraminidase (Neu) inhibition protected against disease onset; however, the source and identity of the Neu enzyme(s) responsible remained unknown. Herein, we report that the mammalian Neu3 neuraminidase is responsible for intestinal IAP desialylation and deficiency. Absence of Neu3 thereby prevented the accumulation of lipopolysaccharide-phosphate and inflammatory cytokine expression in providing protection against the development of severe colitis.
Keyphrases
- toll like receptor
- oxidative stress
- endothelial cells
- inflammatory response
- ulcerative colitis
- poor prognosis
- anti inflammatory
- immune response
- nuclear factor
- induced pluripotent stem cells
- insulin resistance
- early onset
- copy number
- long non coding rna
- risk assessment
- candida albicans
- replacement therapy
- pluripotent stem cells
- binding protein